Profile | GDS4284 / 242732_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 631.621 | 67 |
GSM687648 | Patient 402 control | 209.584 | 50 |
GSM687653 | Patient 403 control | 827.191 | 72 |
GSM687658 | Patient 404 control | 822.528 | 71 |
GSM687663 | Patient 411 control | 1415.77 | 79 |
GSM687668 | Patient 422 control | 1556.31 | 80 |
GSM687673 | Patient 424 control | 2121.58 | 85 |
GSM687678 | Patient 425 control | 305.779 | 55 |
GSM687683 | Patient 427 control | 831.471 | 70 |
GSM687688 | Patient 428 control | 2733.64 | 88 |
GSM687695 | Patient 441 control | 301.329 | 49 |
GSM687699 | Patient 443 control | 612.011 | 66 |
GSM687704 | Patient 444 control | 2830.43 | 88 |
GSM687707 | Patient 448 control | 2544.34 | 87 |
GSM687712 | Patient 449 control | 809.299 | 71 |
GSM687719 | Patient 450 control | 760.567 | 69 |
GSM687724 | Patient 451 control | 2344.25 | 86 |
GSM687728 | Patient 452 control | 652.212 | 68 |
GSM687646 | Patient 401 treated 24h | 754.668 | 69 |
GSM687649 | Patient 402 treated 24h | 377.275 | 60 |
GSM687665 | Patient 411 treated 24h | 1231.49 | 77 |
GSM687651 | Patient 402 treated 4 weeks | 368.906 | 58 |
GSM687667 | Patient 411 treated 4 weeks | 955.259 | 73 |
GSM687670 | Patient 422 treated 24h | 1947.44 | 83 |
GSM687671 | Patient 422 treated 4 weeks | 1497.45 | 80 |
GSM687654 | Patient 403 treated 24h | 977.192 | 74 |
GSM687675 | Patient 424 treated 24h | 1089.07 | 75 |
GSM687685 | Patient 427 treated 24h | 703.682 | 68 |
GSM687656 | Patient 403 treated 4 weeks | 1176.61 | 76 |
GSM687677 | Patient 424 treated 4 weeks | 2977.26 | 89 |
GSM687687 | Patient 427 treated 4 weeks | 912.422 | 72 |
GSM687692 | Patient 428 treated 4h | 956.282 | 73 |
GSM687716 | Patient 449 treated 4h | 882.855 | 72 |
GSM687722 | Patient 450 treated 4h | 657.526 | 67 |
GSM687680 | Patient 425 treated 24h | 280.491 | 54 |
GSM687690 | Patient 428 treated 24h | 1083.09 | 76 |
GSM687700 | Patient 443 treated 24h | 798.418 | 69 |
GSM687705 | Patient 444 treated 24h | 3015.32 | 89 |
GSM687714 | Patient 449 treated 24h | 603.067 | 67 |
GSM687721 | Patient 450 treated 24h | 663.432 | 67 |
GSM687682 | Patient 425 treated 4 weeks | 340.812 | 58 |
GSM687694 | Patient 428 treated 4 weeks | 831.77 | 71 |
GSM687702 | Patient 443 treated 4 weeks | 614.061 | 66 |
GSM687718 | Patient 449 treated 4 weeks | 960.377 | 74 |
GSM687723 | Patient 450 treated 4 weeks | 538.292 | 64 |
GSM687661 | Patient 404 treated 4h | 799.998 | 71 |
GSM687710 | Patient 448 treated 4h | 2320.89 | 86 |
GSM687726 | Patient 451 treated 4h | 2423.63 | 86 |
GSM687730 | Patient 452 treated 4h | 670.39 | 64 |
GSM687660 | Patient 404 treated 24h | 273.078 | 51 |
GSM687697 | Patient 441 treated 24h | 1258.79 | 78 |
GSM687709 | Patient 448 treated 24h | 2725.34 | 88 |
GSM687725 | Patient 451 treated 24h | 2307.35 | 86 |
GSM687729 | Patient 452 treated 24h | 425.302 | 60 |
GSM687727 | Patient 451 treated 4 weeks | 6539.78 | 95 |
GSM687731 | Patient 452 treated 4 weeks | 702.796 | 68 |